Affiliation:
1. Department of Pharmaceutics, College of Pharmaceutical Sciences, Pravara Institute of Medical Sciences (DU), Loni, Ahmednagar, Maharashtra, India.
Abstract
Cancer continues to be a major cause of sickness and death in the world's health. Conventional cancer treatments, such radiation and chemotherapy, frequently have drawbacks like poor solubility, limited absorption, and non-specific targeting, which can result in systemic toxicity and decreased efficacy. To get over these restrictions and improve cancer therapy, nanosuspensions—submicron colloidal dispersions of drug particles stabilized by polymers and/or surfactants—have become a viable new approach. This review provides a comprehensive overview of nanosuspensions, including their preparation methods, characterization techniques, and therapeutic applications in cancer treatment. The potential advantages of nanosuspensions over conventional formulations, such as improved solubility, enhanced bioavailability, and tumor-targeted delivery, are discussed in detail. The potential advantages of nanosuspensions over conventional formulations, such as improved solubility, enhanced bioavailability, and tumor-targeted delivery, are discussed in detail. Recent advances in nanosuspension technology, including the development of stimuli-responsive and multifunctional nanosuspensions, are also highlighted. Recent advances in nanosuspension technology, including the development of stimuli-responsive and multifunctional nanosuspensions, are also highlighted. Finally, the challenges and future directions of nanosuspensions in cancer therapy are explored.
Reference30 articles.
1. Maeda HA, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Critical Reviews in Therapeutic Drug Carrier Systems. 1989 Jan 1; 6(3):193-210.
2. Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. Journal of Pharmacy and Pharmacology. 2004 Jul; 56(7):827-40.
3. Ali HS, York P, Blagden N. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. International Journal of Pharmaceutics. 2009 Jun 22; 375(1-2):107-13.
4. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacological Reviews. 2001 Jun 1; 53(2):283-318.
5. De Verdiere AC, Dubernet C, Nemati F, Poupon MF, Puisieux F, Couvreur P. Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells. Cancer Chemotherapy and Pharmacology. 1994 Nov; 33:504-8.